Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Baird Medical Investment Holdings (BDMD) Other Accumulated Expenses (2023 - 2025)

Historic Other Accumulated Expenses for Baird Medical Investment Holdings (BDMD) over the last 3 years, with Q2 2025 value amounting to $4.5 million.

  • Baird Medical Investment Holdings' Other Accumulated Expenses changed N/A to $4.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $4.5 million, marking a year-over-year change of. This contributed to the annual value of $3.7 million for FY2024, which is 215.44% down from last year.
  • Baird Medical Investment Holdings' Other Accumulated Expenses amounted to $4.5 million in Q2 2025.
  • Over the past 5 years, Baird Medical Investment Holdings' Other Accumulated Expenses peaked at $4.5 million during Q2 2025, and registered a low of $3.7 million during Q4 2024.
  • For the 3-year period, Baird Medical Investment Holdings' Other Accumulated Expenses averaged around $4.0 million, with its median value being $3.8 million (2023).
  • The largest annual percentage gain for Baird Medical Investment Holdings' Other Accumulated Expenses in the last 5 years was 215.44% (2024), contrasted with its biggest fall of 215.44% (2024).
  • Quarter analysis of 3 years shows Baird Medical Investment Holdings' Other Accumulated Expenses stood at $3.8 million in 2023, then decreased by 2.15% to $3.7 million in 2024, then grew by 21.57% to $4.5 million in 2025.
  • Its Other Accumulated Expenses was $4.5 million in Q2 2025, compared to $3.7 million in Q4 2024 and $3.8 million in Q4 2023.